Total Payments
$4,934
2024 Payments
$583.79
Companies
21
Transactions
178
Medicare Patients
2,407
Medicare Billing
$132,193
Payment Breakdown by Category
Food & Beverage$3,478 (70.5%)
Travel$1,442 (29.2%)
Education$13.89 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,478 | 167 | 70.5% |
| Travel and Lodging | $1,442 | 10 | 29.2% |
| Education | $13.89 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,685 | 14 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $579.31 | 40 | $0 (2024) |
| PFIZER INC. | $369.13 | 24 | $0 (2024) |
| Abbott Laboratories | $328.05 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $283.63 | 10 | $0 (2023) |
| Amgen Inc. | $281.35 | 7 | $0 (2023) |
| Esperion Therapeutics, Inc. | $248.75 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $223.81 | 10 | $0 (2024) |
| Boston Scientific Corporation | $188.73 | 7 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $115.71 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $583.79 | 33 | Novartis Pharmaceuticals Corporation ($195.01) |
| 2023 | $791.19 | 38 | Merck Sharp & Dohme LLC ($197.60) |
| 2022 | $2,552 | 58 | Medtronic, Inc. ($1,685) |
| 2021 | $1,007 | 49 | Esperion Therapeutics, Inc. ($237.11) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Heart Failure | ||||||
| 09/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/31/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/23/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 668 | 1,092 | $217,538 | $33,278 |
| 2022 | 11 | 581 | 895 | $156,096 | $31,660 |
| 2021 | 11 | 610 | 910 | $125,956 | $35,734 |
| 2020 | 12 | 548 | 770 | $135,760 | $31,522 |
Total Patients
2,407
Total Services
3,667
Medicare Billing
$132,193
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 170 | $69,267 | $12,628 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 174 | $50,260 | $7,755 | 15.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 23 | 185 | $35,136 | $4,456 | 12.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 21 | 179 | $23,897 | $2,736 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $10,220 | $1,730 | 16.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 144 | 166 | $13,965 | $1,392 | 10.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 13 | 15 | $3,836 | $746.80 | 19.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 54 | $795.00 | $453.60 | 57.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 13 | 32 | $4,207 | $429.84 | 10.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 19 | 20 | $1,566 | $262.40 | 16.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 24 | 27 | $1,501 | $223.83 | 14.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 29 | $1,470 | $220.69 | 15.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 11 | 11 | $953.92 | $149.45 | 15.7% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 11 | 11 | $465.41 | $94.38 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 196 | 238 | $54,057 | $12,072 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 149 | $49,777 | $11,566 | 23.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2022 | 21 | 131 | $21,056 | $3,269 | 15.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2022 | 20 | 129 | $14,626 | $2,178 | 14.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 78 | 95 | $6,840 | $817.08 | 11.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 13 | 17 | $3,865 | $786.94 | 20.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 26 | 28 | $1,273 | $234.37 | 18.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 16 | 16 | $1,107 | $211.55 | 19.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 15 | 15 | $1,797 | $184.22 | 10.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 23 | 24 | $1,033 | $184.16 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 49 | 53 | $665.00 | $156.96 | 23.6% |
About Amanda Partin, RN
Amanda Partin, RN is a Registered Nurse healthcare provider based in Lake Charles, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1750890349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Partin, RN has received a total of $4,934 in payments from pharmaceutical and medical device companies, with $583.79 received in 2024. These payments were reported across 178 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,478).
As a Medicare-enrolled provider, Partin has provided services to 2,407 Medicare beneficiaries, totaling 3,667 services with total Medicare billing of $132,193. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner
- Location Lake Charles, LA
- Active Since 09/26/2017
- Last Updated 07/21/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1750890349
Products in Payments
- ELIQUIS (Drug) $391.02
- LEQVIO (Drug) $299.64
- VERQUVO (Drug) $283.63
- Repatha (Biological) $281.35
- ENTRESTO (Drug) $279.67
- CARDIOMEMS (Device) $218.82
- FARXIGA (Drug) $149.17
- NEXLETOL (Drug) $137.53
- LifeVest (Device) $115.71
- XARELTO (Drug) $113.04
- NEXLIZET (Drug) $111.22
- Vascepa (Drug) $102.91
- JARDIANCE (Drug) $100.83
- WATCHMAN Access System (Device) $90.04
- WATCHMAN FLX (Device) $64.75
- Impella (Device) $61.45
- Kerendia (Drug) $52.08
- OPTIMIZER (Device) $51.77
- BRILINTA (Drug) $48.28
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $46.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Lake Charles
Chad Hodge, Rn, RN
Registered Nurse — Payments: $8,415
Registered Nurse $8,415
Megan Clemons, Aprn, Fnp-C, APRN, FNP-C
Registered Nurse — Payments: $2,768
Registered Nurse $2,768
Codie Lee Guidry, N.p, N.P
Registered Nurse — Payments: $1,775
Registered Nurse $1,775
Mrs. Raquel Morrow, Aprn, Fnp-C, APRN, FNP-C
Registered Nurse — Payments: $1,547
Registered Nurse $1,547
Mr. James Brooks, Crna, CRNA
Registered Nurse — Payments: $389.03
Registered Nurse $389.03
Mr. Jeremy Morris, Rn, RN
Registered Nurse — Payments: $340.53
Registered Nurse $340.53